Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2009/053373external-prioritypatent/WO2010019550A2/en
Application filed by Zinfandel Pharmaceuticals IncfiledCriticalZinfandel Pharmaceuticals Inc
Publication of TN2011000047A1publicationCriticalpatent/TN2011000047A1/en
Measuring Or Testing Involving Enzymes Or Micro-Organisms
(AREA)
Abstract
Provided herein is a method for identifying a genetic variant that is associated with development of a condition of interest (e.g., Alzheimer's disease), and genetic variants so identified. Methods of treatment with an active agent (e.g., with a particular active agent and/or at an earlier age) is also provided, upon detecting a genetic variant described herein. In some embodiments, the genetic variant is a deletion/insertion polymorphism (DIP) of the TOMM40 gene. Kits for determining if a subject is at increased risk of developing late onset Alzheimer's disease is also provided. Kits for determining if a subject is responsive to treatment for a condition of interest with an active agent are further provided.
TN2011000047A2009-08-112011-01-27Method of identifying disease risk factors
TN2011000047A1
(en)